- Home
- ELF vs PCVX Comparison
ELF vs PCVX Comparison
Compare ELF & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELF | PCVX |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 7.0B |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ELF | PCVX |
|---|---|---|
| Price | $53.29 | $49.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 4 |
| Target Price | ★ $111.88 | $88.25 |
| AVG Volume (30 Days) | ★ 3.5M | 1.6M |
| Earning Date | 05-27-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.44 | N/A |
| Revenue | ★ $1,636,472,000.00 | N/A |
| Revenue This Year | $23.87 | N/A |
| Revenue Next Year | $17.15 | N/A |
| P/E Ratio | $120.08 | ★ N/A |
| Revenue Growth | ★ 24.59 | N/A |
| 52 Week Low | $49.72 | $29.10 |
| 52 Week High | $150.99 | $65.00 |
Technical Indicators
Market Signals| Indicator | ELF | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 39.85 | 39.93 |
| Support Level | N/A | $42.30 |
| Resistance Level | $96.30 | $56.04 |
| Average True Range (ATR) | 3.17 | 2.47 |
| MACD | -0.10 | -0.51 |
| Stochastic Oscillator | 31.41 | 34.37 |
Price Performance
Historical ComparisonAbout ELF e.l.f. Beauty Inc.
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skin care products. The Company's mission is to make beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women, which include eyeliner, mascara, false eyelashes, lipstick, foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.